Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals June 9, 2020June 9, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailAgreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution Related News: Ellutia introduces fully automated total nitrosamine…Providing a New Tool for Developing Manufacturing…Agilent Receives FDA Companion Diagnostic Approval…Roche’s VENTANA PD-L1 (SP263) Assay receives FDA…Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark…FDA Approves NGS-Based Companion Diagnostic for EGFR…
